• JPMorgan Chase cut its Abivax stake below the 5% disclosure threshold on June 23, holding 3,731,313 shares, or 4.68% of capital.
• It moved back above 5% on June 24 with 4,277,848 shares, or 5.36%.
• JPMorgan then slipped below 5% again on June 25, reporting 3,881,327 shares, or 4.86%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief on July 21, 2026, and is solely responsible for the information contained therein.